Roche and Avista team up on AAV gene therapy vectors for eye diseases
Avista Therapeutics, a University of Pittsburgh Medical Center (UPMC) spinout, is teaming up with Roche to develop novel AAV gene therapy vectors for eye diseases.
Archives for July 26, 2022
Biogen wins FDA priority review for ALS therapy
Biogen says US FDA is reviewing an NDA for tofersen, an investigational drug for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS).
CDC calls for increased research into vaccines, therapeutics and diagnostics to tackle antimicrobial resistance
The US Centers for Disease Control and Prevention (CDC) says COVID-19 has ‘pushed back years of progress’ in combating antimicrobial resistance (AR) in the US – adding that the threat from AR has also got worse.
New investment in monkeypox vaccine assessment tools
The Coalition for Epidemic Preparedness Innovations (CEPI) will provide funding of up to $375,000 to the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the UK Health Security Agency (UKHSA) to support the development of laboratory...